The interaction of PD-1/PD-L1 in the tumor microenvironment can promote T cell dysfunction, failure, apoptosis, neutralization, and the formation of IL-10, thus enhancing the proliferation and survival of tumor cells to promote the development and progression of cancer (Akinleye and Rasool, 2019). The gene discussed is PDCD1; the disease is cancer.